Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Pemetrexed (LY231514, Alimta) in Children and Adolescents With Recurrent Solid Tumors

NCT00070473 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00070473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00070473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Pemetrexed (LY231514, Alimta) in Children and Adolescents With Recurrent Solid Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2003
Completion date
June 30, 2008
Enrollment
33 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified childhood solid tumor, protocol specific